How we know
Every link on this study, and who decided it
The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.
22 links0 made here, not in the record24 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.
Rucaparib
From the registry record2 judgments on this linkRole in the study, from the registry to what was judged
RegistryEntry “Rucaparib”the record gives no role
→judged=agreesHow the 2 judgments split100%of judgments with a known value say Background · partner
Background · partner · 2
All judgments on this study
| When | Link | Judge | Decision | State |
|---|---|---|---|---|
| Nov 10 | Rucaparib | Claude Opus 5.5 | Background · partner | Current |
| Nov 14 | Lymphoma | Our condition-kind rule | General: a category, not a disease | Current |
| Nov 14 | Leukemia | Our condition-kind rule | General: a category, not a disease | Current |
| Nov 14 | Myelodysplastic Syndromes | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Multiple Myeloma | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Myeloproliferative Disorders | Our condition-kind rule | Wider: a narrower term is filed | Current |
| Nov 14 | Primary Myelofibrosis | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Pancreatic Neoplasms | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Colorectal Neoplasms | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Carcinoma, Non-Small-Cell Lung | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Prostatic Neoplasms | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Breast Neoplasms | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Ovarian Neoplasms | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Glioblastoma | Our condition-kind rule | Finest filed term | Current |
| Nov 14 | Lymphoma, Non-Hodgkin | Our condition-kind rule | General: a category, not a disease | Current |
| Nov 14 | Lymphoma, Large B-Cell, Diffuse | Our condition-kind rule | Finest filed term | Current |
| Nov 18 | INCB057643 | Our role rule | Tested | Current |
| Nov 18 | Gemcitabine | Our role rule | Background | Current |
| Nov 18 | Paclitaxel | Our role rule | Background | Current |
| Nov 18 | Rucaparib | Our role rule | Background | Agrees |
| Nov 18 | Abiraterone | Our role rule | Background | Current |
| Nov 18 | Ruxolitinib | Our role rule | Background | Current |
| Nov 18 | Azacitidine | Our role rule | Background | Current |
| As of now | Lymphoma | Our main-condition rule (R9) | Main condition | Current |